Cancer Prevention Pharmaceuticals, Inc. engages in the development and production of pharmaceutical agents to prevent cancers in people with elevated risk for these diseases in the United States. The company offers difluoromethylornithine for clinical cancer prevention and treatment trials. It also develops diagnostic methods to identify individuals who are at high risk for specific cancers and medicine-related toxicities. In addition, the company develops cancer chemoprevention indications for common cancers along with prevention and therapeutic strategies in certain rare cancers. Cancer Prevention Pharmaceuticals, Inc. was incorporated in 2008 and is based in Tucson, Arizona.

Patents 21show all

  • 5
    A61K - Preparations for medical, dental, or toilet purposes
  • 4
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
  • 4
    C07K - Peptides
  • 4
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms

Clinical Trials 13show all

9Phase 33Phase 21Phase 1

SEC Filings show all


7
D

1
S-1

Contact Information

1760 E. River Road, Suite 250
Tucson, AZ 85718
United States

Overview

Total FundingEmployeesLast Funding DateStatus
$16,072,5001-102017-09-11Operating

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2009-08-17$1,250,000Debt Financing
2011-03-09$550,000Debt Financing
2017-09-11$5,000,000Undisclosed
2013-10-31$4,272,500Series Unknown
2016-01-27$5,000,000Debt Financing

SEC Form D Funding Events

DateOfferedSoldType
2013-10-31$6,000,000$4,272,500Equity
2011-03-24$2,000,000$550,000Debt
2009-09-01$2,000,000$1,250,000Debt, Option to Acquire, Security to be Acquired

Key Executives

  • Eugene W Gerner
    Director
  • Frank Meyskens
    Director
  • Jeffrey Jacob
    Director
  • Jeffrey E Jacob
    Executive Officer, Director
  • Richard Love
    Director
  • Daniel Donovan
    Director